Moody’s affirms ‘A2’ rating on Renown Health

Moody’s Investors Service affirmed its “A2” rating on Reno,  Nev.-based Renown Health, affecting $448 million of rated debt.

Advertisement

The affirmation is a result of several factors, including the health system’s growing balance sheet, improving debt metrics, significant size, strong market position and its wide range of clinical offerings.

The outlook is stable, reflecting Moody’s expectation that Renown’s strong market position and the absence of debt plans will continue to grow Renown’s balance sheet and improve operations.

More articles on healthcare finance:
Health IT, RCM sectors see $3.3B in mergers, acquisitions in year’s first half
44 RCM promotions, hires in 2018
Fellow Health Partners acquires medical billing company

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.